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Editorial on the Research Topic
Alexithymia: State of the Art and Controversies. Clinical and Neuroscientific Evidence
The relevance of alexithymia has grown exponentially in the past decades. It is currently considered
a relevant concept for several psychological and physical disorders (Taylor and Bagby, 2004; Di
Tella and Castelli, 2013, 2016), and increasing attention is paid to its relationships with other
psychological constructs. From a neuroscientific standpoint, an increasing number of studies
has been aiming at shedding light on the neuro-anatomical/-functional correlates of alexithymia.
The studies included in the present research topic reflect this manifold panorama. Specifically,
some studies investigated the relationship between alexithymia and other clinical conditions,
i.e., gastrointestinal/hepatological disorders, headache, substance use disorders, autism spectrum
disorders (ASD), functional blindness and fibromyalgia. A second block of studies focused on
the association between alexithymia and other clinically relevant psychological constructs such as
type-D personality, self-harm, emotional recognition and awareness, implicit and explicit positive
and negative affectivity. Finally, three studies analyzed neurological/neuro-vegetative aspects.
Among those articles that investigate the prevalence and the impact of alexithymia in medical
disorders, Carrozzino and Porcelli systematically reviewed the literature investigating the role
of alexithymia in “organic” and “functional” gastrointestinal disorders. Alexithymia, and in
particular the difficulty identifying and communicating feelings, were found to be more prevalent
in functional gastrointestinal disorders (FGIDs) than in organic ones (i.e., inflammatory bowel
disease or liver diseases), with a prevalence of 60% or more vs. 30–50%, respectively. Empirical
evidence also suggested that alexithymia is mainly associated to the subjective dimension of
health perception, including somatization, symptom persistence, and, above all, negative treatment
outcomes. Kano et al. confirmed the association between alexithymia and FGIDs, focusing on the
possible mechanism underlying this association. Although empirical evidence proposed several
contributing factors, such as somatosensory amplification, visceral hypersensitivity or alteration
of the stress response system, the specific mechanism linking alexithymia and FGIDs still remains
unclear. The fact that alexithymia is mainly associated to the clinical outcomes related to the
subjective dimension of health perception was confirmed by a study on a different functional
syndrome, i.e., fibromyalgia. Indeed, Tesio et al. found that alexithymia contributes both directly
and indirectly, through the mediation of depressive symptoms, to worsen the impact that this
chronic pain pathology has on the patients’ quality of life, especially regarding their psychosocial
functioning. Another rare functional syndrome, a conversion disorder called non-organic vision
loss (NOVL), was investigated by the research paper of Scarpina et al. They found that two patients
with NOVL judged themselves as competent in emotional processing on the Toronto Alexithymia
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Scale (TAS-20; Bagby et al., 1994a,b), but showed a selective
deficit in efficiently recognizing the emotion of fear in a
behavioral experimental task. These data suggested a mismatch
between the patients’ subjective evaluation and their actual
emotional processing performance.
Natalucci et al. reviewed the few studies on the relation
between alexithymia and primary headache (e.g., migraine and
tension type headache) in children and adolescents. A general
consensus on high levels of alexithymia in this population
emerged. The authors suggested that the association between
alexithymia and headache could be moderated by insecure
attachment or by an incomplete development of emotive
competency, whichmay result in a deficit in emotional regulation
and expression. The difficulties in emotional regulation and the
lack of emotional awareness, possibly consequent to alexithymia,
could compromise the understanding of others’ emotions, giving
rise to problems in social interaction. The deficit in social
competences of people with ASD prompted several authors to
investigate the association between alexithymia andASD. Aiming
to evaluate the state of the art, Poquérusse et al. argued that,
in spite of the high amount of studies focusing on emotional,
social and cognitive features shared by alexithymia and ASD,
the nature of this relationship remains unclear. Nevertheless, the
scientific evidence seems to support the “alexithymia hypothesis,”
i.e., alexithymia, not ASD, would be the main cause of the
emotional deficits in ASD. Despite it having been associated
with several medical and psychiatric disorders, a recent point
of view speculated that alexithymia, rather than characterizing
distinct disorders, might bemore associated with specific features
regarding psychological distress or negative affectivity. Along
this line of thought, both the absence of differences between
drug-dependent inpatients and psychiatric patients, and the
limited ability of alexithymia in predicting treatment outcome
led Parolin et al. to question the specificity of alexithymia in
substance-dependent patients.
Moving to the articles that focus on the association
between alexithymia and other clinically relevant psychological
constructs, Suslow and Donges studied its relations with both
implicit and explicit positive and negative affectivity. They
concluded that there was no substantial relationship between
alexithymia and positive affect in healthy adults. However,
the difficulties identifying feelings (DIF) factor of the TAS-20
appeared to be associated with an increased conscious experience
of negative affect, but not with a heightened disposition for
negative affect at an automatic response level. Regarding negative
affect, also Epifanio et al. evidenced a strong positive correlation
of the negative affectivity factor of the type-D personality with
both the DIF and the DDF (difficulty describing feelings) factors
of alexithymia. Nevertheless, they confirmed that alexithymia
and type-D personality are distinct constructs, with alexithymia
being at the base of affect dysregulation underlying the type-D
way to cope with emotions. According to Cerutti et al. also
non-suicidal self-injury (i.e., the intentional injuring of one’s
body without apparent suicidal intent) could be regarded as a
way to cope with emotions in adolescents with difficulties in
identifying and describing feelings. In particular, they proposed
a theoretical model in which the difficulty in identifying and
describing feelings is a mediator of the associations between non-
suicidal self-injury and quality of attachment toward both parents
and peers.
Emotional awareness is another construct closely related to
alexithymia. Both encompass potential difficulties in identifying
and describing one’s own and others’ feelings, but emotional
awareness does not entail limited imaginal ability and externally-
oriented thinking. Going further to the partial theoretical
overlap, Maroti et al. conducted a meta-analysis of the
correlations between the most commonly used measures of
alexithymia (TAS-20) and emotional awareness (the Level of
Emotional Awareness Scale; LEAS) to explore how the constructs
relate to each other empirically. The only small overlap between
the two instruments suggested that theymeasure different aspects
of emotional functioning, confirming that alexithymia and
emotional awareness are distinct constructs of emotional well-
being. The last considered deficit associated with alexithymia
is the identification of emotional facial expressions, a crucial
mechanism for social interactions. Starita et al. found that
participants with high vs. low levels of alexithymia need more
emotional intensity to identify static fearful faces, whereas no
differences emerged in the identification of dynamic emotional
facial expressions. The fact that alexithymia is related to the need
for more perceptual information to identify static fearful, but not
happy or disgusted facial expressions might be related to partially
different brain networks involved.
The latest articles selected for this research topic are
focused on the neurobiological correlates of alexithymia.
Lischke et al. investigated the association of the vagally
mediated heart rate variability (vmHRV) with alexithymia and
empathy. vmHRV is a parasympathetical biomarker of the
engagement of prefrontal and (para-)limbic brain regions during
the regulation of emotional and cognitive processes. Results
confirmed that individuals with high vmHRV, which are thus
more efficient in recruiting prefrontal and (para-)limbic brain
regions implicated in the simulation and interpretation of
emotional and mental states, showed more empathy and lower
levels of alexithymia than individual with low vmHRV. The
introspection-centric simulation theory (IST) predicts that an
inability to accurately identify and describe internal affective
states may lead to empathy difficulties. Resting on the IST,
Valdespino et al. hypothesized that alexithymia may not only
be correlated with, but might even cause empathic deficits.
Indeed, in their review, they argued that alexithymia and its
associated insula pathology could be considered a potential
common cognitive and neural marker of empathy deficits across
several diagnostic categories. Finally, Goerlich’s perspective
paper reviewed neuroimaging studies that differentiated the
alexithymia facets and dimensions, in order to highlight their
dissociable substrates. Results indicated that the DIF and, to a
lesser extent, the DDF factors of the TAS-20 usually correlate with
emotion-related areas, while the externally oriented thinking
factor showed little effect on the function and structure of
these brain regions. For example, one large study confirmed
a special role of DIF on volumes of the dorsal anterior
cingulate cortex, a key region for emotional self-awareness,
and other studies linked the DIF factor to a dysfunction
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of the amygdala during the processing of emotions with
negative valence.
Taken together, the articles included in the present research
topic clearly highlight the clinical relevance and the complexity
of the alexithymia construct, which can be considered transversal
to different medical and psychiatric conditions besides being
strongly linked to many relevant psychological constructs,
like type-D personality. Since psychological factors are more
and more recognized as key predictive factors for therapeutic
response to treatments (Castelnuovo et al., 2016), further
research should investigate the specific role of alexithymia as
a potentially relevant outcome predictor, both for medical and
psychological conditions.
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